Unlocking the Genome: The Legal Case against Genetic Diagnostic Patents

By Russell, Tiana Leia | Marquette Intellectual Property Law Review, Winter 2012 | Go to article overview

Unlocking the Genome: The Legal Case against Genetic Diagnostic Patents


Russell, Tiana Leia, Marquette Intellectual Property Law Review


I. INTRODUCTION
II. PATENTING PROCESSES
III. PATENTS ON GENETIC DIAGNOSTIC METHODS
       A. Science of Genes
       B. The History of Gene Patents
       C. Association for Molecular Pathology v. USPTO
       D. Patents on Mixed Diagnostic-Therapeutic
IV. POLICY ARGUMENTS AGAINST DIAGNOSTIC GENETIC
       PATENTS
       A. Advanced Diagnostics Patents Are Unnecessary to
           Motivate Innovation
       B. Upstream and Downstream Effects of Genetic Diagnostic
           Patents
       C. A Lower Standard of Care
V. CONCLUSION

I. INTRODUCTION

We are on the leading edge of a true revolution in medicine, one that promises to transform the traditional 'one size fits all' approach into a much more powerful strategy that considers each individual as unique and as having special characteristics that should guide an approach to staying healthy. Although the scientific details to back up these broad claims are still evolving, the outline of a dramatic paradigm shift is coming into focus. (1)

Francis S. Collins, Director of National Institutes of Health

The growth of personalized medicine, which aims to better customize and target treatments to patients through the use of information about an individual's genes, proteins, and environment, is changing the healthcare industry and holds tremendous potential to improve patients' lives. The medical diagnostics field is a key attribute of personalized medicine, as simple tests measuring levels of proteins, genes, or mutations can be performed on patients to optimize specific therapies for that individual's condition. In many cases, this individualized treatment avoids costly, unnecessary, and potentially dangerous procedures.

Within the medical diagnostics field, genetic diagnostic methods are rapidly changing the way diseases are diagnosed, prevented, and treated. The ability to link genetic mutations to specific diseases can lead to improved diagnostics, higher quality health care and, in some instances, life-saving treatments. Current estimates place the number of inheritable diseases stemming from mutated genes at four thousand. (2) Thus far, genetic information has been used to assist physicians in individualizing treatments for their patients in a variety of contexts. And, "most of the promise offered by the sequencing of the human genome still lies ahead." (3)

Although personalized medicine remains in its early stages, its potential to improve patients' lives cannot be overstated. However, translating this seemingly limitless scientific revolution into tangible benefits for patients and ensuring that these discoveries are accessible on reasonable and fair terms to patients promises to be a difficult challenge. As our understanding of the linkages between genetic mutations and diseases has grown, so has a heated debate over whether patents on genes are deserving of patent protection. Currently, genetic diagnostic methods can be broadly claimed in a patent. (4) These diagnostic gene patents typically involve the process of comparing a particular portion of a patient's genetic sequence to a wild-type or mutation sequence in order to diagnose a genetic predisposition or disease. These patents oftentimes claim every single known and possible method for looking at the DNA sequence, including many of the standard processes regularly employed in the field. Over the past few decades, the U.S. Patent and Trademark Office (PTO) has granted thousands of patents on human genes, many of these directed towards diagnostic methods. Presently, patents are held on diagnostic tests tied to a wide array of diseases including prostate cancer, (5) HIV/AIDS, (6) breast cancer, (7) ovarian cancer, (8) and vitamin B deficiencies. (9) Half of the genes known to be connected to cancer are already patented, and one company alone holds patents on approximately ten percent of the human genome. Whether such advanced diagnostic methods should be afforded patent protection is of increasing significance as our understanding of the makeup of the human genome grows. …

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Unlocking the Genome: The Legal Case against Genetic Diagnostic Patents
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.